title: Empowering the child and caregiver: yellow zone Asthma Action Plan.
abstract: Current guidelines, both national and international, elegantly describe evidence-based measures to attain and maintain long-term control of asthma. These strategies, typically discussed between the provider and patient, are provided in the form of written (or electronic) instructions as part of the green zone of the color-coded Asthma Action Plan. The red zone of the Asthma Action Plan has directives on when to use systemic corticosteroids and seek medical attention. The transition zone between the green zone of good control and the red zone of asthma exacerbation is the yellow zone. This zone guides the patient on self-management of exacerbations outside a medical setting. Unfortunately, the only recommendation currently available to patients per the current asthma guidelines is the repetitive use of reliever bronchodilators. This approach, while providing modest symptom relief, does not reliably prevent progression to the red zone. In this document, we present new, evidence-based, yellow zone intervention options.
authors.affiliation: Division of Allergy, Asthma and Immunology, Children's Mercy Hospitals, University of Missouri-Kansas City, 2401 Gillham Road, Kansas City, MO, 64108, USA, cdinakar@cmh.edu.
authors.forename: Chitra
authors.initials: C
authors.lastname: Dinakar
authors.forename: Jay M
authors.initials: JM
authors.lastname: Portnoy
mesh_terms: D000305:Adrenal Cortex Hormones / Q000008:administration & dosage*; D000318:Adrenergic beta-Agonists / Q000008:administration & dosage*; D018927:Anti-Asthmatic Agents / Q000008:administration & dosage*; D001249:Asthma / Q000175:diagnosis / Q000188:drug therapy* / Q000503:physiopathology; D017028:Caregivers; D002648:Child; D006801:Humans; D011209:Power, Psychological; D012648:Self Care
chemical_list: D000305:Adrenal Cortex Hormones; D000318:Adrenergic beta-Agonists; D018927:Anti-Asthmatic Agents